LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Rare pulmonary disease and orphan drugs: a path to the future

Photo from archive.org

In this issue of the European Respiratory Review (ERR), we are delighted to publish a series of articles on rare pulmonary diseases discussing hot topics presented at the 8th International… Click to show full abstract

In this issue of the European Respiratory Review (ERR), we are delighted to publish a series of articles on rare pulmonary diseases discussing hot topics presented at the 8th International Meeting on Pulmonary Rare Diseases and Orphan Drugs, which took place in Milan, Italy in March 2019. The meeting was endorsed by the European Respiratory Society and the European Reference Network – LUNG; a network of healthcare providers dedicated to the care and investigation of patients suffering from rare respiratory diseases approved by the European Commission's Board of Member States in December 2016 (https://ec.europa.eu/health/ern/networks_en) [1]. The interest in rare diseases is growing. The progress in this field has been made possible by a coordinated action between respiratory researchers, health authorities and patients associations. http://bit.ly/2kIurPH

Keywords: rare pulmonary; disease orphan; orphan drugs; european respiratory; respiratory; pulmonary disease

Journal Title: European Respiratory Review
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.